Prof. Alberto Albanese is the Neurology Unit Director at Humanitas Research Hospital. Until recently – Department Head of Neuroscience at the Institute of Neurology Carlo Besta (Milan). In 1977 prof. Albanese received his degree in medicine and surgery, in 1981 – in neurology, and in 1985 – in psychiatry. His professional experience began with the founding of the Department of “disorders of Parkinson’s and violations of the musculoskeletal system” at the clinic “A. Gemelli “in Rome in 1984, which he led until 1996. From 1996 to 2000 prof. Albanese was the Head of the Neurological University Clinic of Lausanne (Switzerland) and a professor of Neurology in the University.
From 2000 to 2015 he was Head of Neuroscience Department at the Institute of Neurology Carlo Besta (Milan).
Prof. Albanese is a professor of neurology at the Institute of Neurology at the Catholic University of the Sacred Heart (Milan), Director of the post-graduate course “Diagnosis and treatment of movement disorders and degenerative neurological diseases” at the Foundation Neurological Institute “C. Besta”, as well as an adjunct professor at the School of Specialization in Neuroscience at the University of Milan Bicocca.
Prof. Albanese is the president of “Italian Association of Parkinson’s disease and movement disorders” and “Italian Association for the Study of the autonomic nervous system” (which are part of “Italian Community of Neuroscience”). He is also an honorary member of the “French Community of Neuroscience.” The professor is a moderator and speaker at major national and international neurological conferences, he organized several symposia dedicated to Neurology, collaborates with numerous national and international research centers, which are studying Parkinson’s disease, movement disorders and degenerative neurological diseases. Prof. Albanese has been repeatedly receiving research fundings from the following government agencies: the Ministry of Health, Ministry of Science and Research, National Research Council, the British Council, the Swiss National Research Council.
He is one of the greatest Italian experts on the diagnosis and treatment of neurological diseases and movement disorders, Parkinson.
He has extensive experience in the use of neurostimulation of brain neurological movement disorders, for treating Parkinson’s disease and other involuntary movements.
He developed the first Italian project on the study of genetic disease and Parkinson’s dystonia, which led to the discovery of two new genetic loci. Also prof. Albanese is actively engaged in research in the field of semiotics detailed definition of involuntary movements, which allows tracking of related clinical pathology for accurate diagnosis of patients with movement disorders.
Prof. Albanese has published more than 200 scientific papers, most of which are published in indexed journals (with a total impact factor>500), is the author of one monograph, 3 books and co-author of numerous books and publications. He is the chief editor of “Frontiers in Movement Disorders” and assistant editor of the “European Journal of Neuroscience”.
Publications: http://www.ncbi.nlm.nih.gov/pubmed?term=albanese a
Mehr lesenProf. Alberto Albanese is the Neurology Unit Director at Humanitas Research Hospital. Until recently – Department Head of Neuroscience at the Institute of Neurology Carlo Besta (Milan). In 1977 prof. Albanese received his degree in medicine and surgery, in 1981 – in neurology, and in 1985 – in psychiatry. His professional experience began with the founding of the Department of “disorders of Parkinson’s and violations of the musculoskeletal system” at the clinic “A. Gemelli “in Rome in 1984, which he led until 1996. From 1996 to 2000 prof. Albanese was the Head of the Neurological University Clinic of Lausanne (Switzerland) and a professor of Neurology in the University.
From 2000 to 2015 he was Head of Neuroscience Department at the Institute of Neurology Carlo Besta (Milan).
Prof. Albanese is a professor of neurology at the Institute of Neurology at the Catholic University of the Sacred Heart (Milan), Director of the post-graduate course “Diagnosis and treatment of movement disorders and degenerative neurological diseases” at the Foundation Neurological Institute “C. Besta”, as well as an adjunct professor at the School of Specialization in Neuroscience at the University of Milan Bicocca.
Prof. Albanese is the president of “Italian Association of Parkinson’s disease and movement disorders” and “Italian Association for the Study of the autonomic nervous system” (which are part of “Italian Community of Neuroscience”). He is also an honorary member of the “French Community of Neuroscience.” The professor is a moderator and speaker at major national and international neurological conferences, he organized several symposia dedicated to Neurology, collaborates with numerous national and international research centers, which are studying Parkinson’s disease, movement disorders and degenerative neurological diseases. Prof. Albanese has been repeatedly receiving research fundings from the following government agencies: the Ministry of Health, Ministry of Science and Research, National Research Council, the British Council, the Swiss National Research Council.
He is one of the greatest Italian experts on the diagnosis and treatment of neurological diseases and movement disorders, Parkinson.
He has extensive experience in the use of neurostimulation of brain neurological movement disorders, for treating Parkinson’s disease and other involuntary movements.
He developed the first Italian project on the study of genetic disease and Parkinson’s dystonia, which led to the discovery of two new genetic loci. Also prof. Albanese is actively engaged in research in the field of semiotics detailed definition of involuntary movements, which allows tracking of related clinical pathology for accurate diagnosis of patients with movement disorders.
Prof. Albanese has published more than 200 scientific papers, most of which are published in indexed journals (with a total impact factor>500), is the author of one monograph, 3 books and co-author of numerous books and publications. He is the chief editor of “Frontiers in Movement Disorders” and assistant editor of the “European Journal of Neuroscience”.
Publications: http://www.ncbi.nlm.nih.gov/pubmed?term=albanese a
Dr. Corrado Lodigiani has been assistant at the Thrombosis Centre of Humanitas research Hospital from 1998 to 2013 and he became Unit Director in 2013.
Humanitas Thrombosis Center is a state-of-the-art service for the proper management of the diagnosis and therapy of venous thromboembolic pathology (deep and superficial venous thrombosis, pulmonary thromboembolism, visceral venous thrombosis) and arterial (myocardial infarction, cerebral stroke, peripheral arterial disease).
Other also rare diseases treated are atypical thrombosis, such as the vascular circulation of the retina, the hearing system and the placental circulation during pregnancy.
Dr. Lodigiani adopts the multidisciplinary approach and works in collaboration with all medical and surgical specialties. In particular, he carries out clinical and instrumental diagnostics (vascular ecocolordoppler) and research on the causes, diagnosis and therapy of thrombotic and bleeding disorders, congenital and acquired. His clinical activity also involves the diagnosis and management of patients suffering from bleeding diseases, such as haemophilia, von Willebrand’s disease and platelet diseases.
In recent years, he has devoted himself with particular interest to the testing, in the role of Principal Investigator in International Clinical Studies, of new antithrombotic drugs and, above all, anticoagulants, which are about to be marketed and will constitute a valid and safe alternative to traditional oral anticoagulant therapy (DOACs). He is also working, with great interest, on researching the causes of idiopathic infertility and the usefulness and effectiveness of some therapeutic strategies, such as the use of anticoagulant drugs, improving the results of artificial insemination procedures. He is the author of numerous articles in international scientific journals and speaker at numerous national and international conferences.
Mehr lesenDr. Corrado Lodigiani has been assistant at the Thrombosis Centre of Humanitas research Hospital from 1998 to 2013 and he became Unit Director in 2013.
Humanitas Thrombosis Center is a state-of-the-art service for the proper management of the diagnosis and therapy of venous thromboembolic pathology (deep and superficial venous thrombosis, pulmonary thromboembolism, visceral venous thrombosis) and arterial (myocardial infarction, cerebral stroke, peripheral arterial disease).
Other also rare diseases treated are atypical thrombosis, such as the vascular circulation of the retina, the hearing system and the placental circulation during pregnancy.
Dr. Lodigiani adopts the multidisciplinary approach and works in collaboration with all medical and surgical specialties. In particular, he carries out clinical and instrumental diagnostics (vascular ecocolordoppler) and research on the causes, diagnosis and therapy of thrombotic and bleeding disorders, congenital and acquired. His clinical activity also involves the diagnosis and management of patients suffering from bleeding diseases, such as haemophilia, von Willebrand’s disease and platelet diseases.
In recent years, he has devoted himself with particular interest to the testing, in the role of Principal Investigator in International Clinical Studies, of new antithrombotic drugs and, above all, anticoagulants, which are about to be marketed and will constitute a valid and safe alternative to traditional oral anticoagulant therapy (DOACs). He is also working, with great interest, on researching the causes of idiopathic infertility and the usefulness and effectiveness of some therapeutic strategies, such as the use of anticoagulant drugs, improving the results of artificial insemination procedures. He is the author of numerous articles in international scientific journals and speaker at numerous national and international conferences.
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Estetik Cerrahi: Deneyimli cerrahlarımızla, güncel teknikleri kullanarak estetik cerrahi hizmetleri sunuyoruz. Her bireyin ihtiyacına özel çözümler üreterek, doğal ve estetik sonuçlar elde etmeyi amaçlıyoruz.
Saç, Sakal ve Kaş Ekimi: Saç dökülmesi, seyrek sakal ya da kaş problemleriyle mücadele edenlere özel çözümler sunuyoruz. Uzman ekibimiz, kişinin yüz hatlarına uygun doğal sonuçlar elde etmeyi hedefler.
Dolgu Uygulamaları: Yüz gençleştirme ve kontürleme amacıyla kullanılan dolgu uygulamalarını, uzman estetik cerrahlarımız ile güvenli bir şekilde gerçekleştiriyoruz. Doğallığı ön planda tutan yaklaşımımızla, müşterilerimize istedikleri görünüme kavuşmalarında yardımcı oluyoruz.
Mehr lesenEstetik Cerrahi: Deneyimli cerrahlarımızla, güncel teknikleri kullanarak estetik cerrahi hizmetleri sunuyoruz. Her bireyin ihtiyacına özel çözümler üreterek, doğal ve estetik sonuçlar elde etmeyi amaçlıyoruz.
Saç, Sakal ve Kaş Ekimi: Saç dökülmesi, seyrek sakal ya da kaş problemleriyle mücadele edenlere özel çözümler sunuyoruz. Uzman ekibimiz, kişinin yüz hatlarına uygun doğal sonuçlar elde etmeyi hedefler.
Dolgu Uygulamaları: Yüz gençleştirme ve kontürleme amacıyla kullanılan dolgu uygulamalarını, uzman estetik cerrahlarımız ile güvenli bir şekilde gerçekleştiriyoruz. Doğallığı ön planda tutan yaklaşımımızla, müşterilerimize istedikleri görünüme kavuşmalarında yardımcı oluyoruz.
Professor Dr. Gökmen
General Surgeon
Professor Dr. Gökmen
General Surgeon
Dr. Samir Göyüşov
Accessory Mental/Buccal Foramina: Case Report and Review of Literature
Goyushov S, Tözüm MD, Tözüm TF.
Journal: Implant Dentistry
Date: October 2017
Transplantation of Autogenous Bone Block with an Osseointegrated Implant: Seedling Technique
[Additional details can be included here if available]
The 2nd Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 2019: Summary and Consensus Statements: Group 1-Biological Aspects of Tooth Extraction, Socket Healing and Indications for Socket Preservation
Gintaras Juodzbalys, Povilas Daugela, Onurcem Duruel, Maria Helena Fernandes, Pedro de Sousa Gomes, Samir Goyushov, Lorena Mariano, Lukas Poskevicius, Arturas Stumbras, Tolga Fikret Tözüm.
Journal: J Oral Maxillofac Res
Date: September 5, 2019
Morphological Classification of Extraction Sockets and Clinical Decision Tree for Socket Preservation/Augmentation after Tooth Extraction: a Systematic Review
Gintaras Juodzhalys, Arturas Stumbras, Samir Goyushov, Onurcem Duruel, Tolga Fikret Tanim.
Journal: J Oral Maxillofac Res
Date: September 5, 2019
Mandibular Cortical Indices and Their Relation to Gender and Age in Cone-Beam Computed Tomography
Samir Goyushov, Erhan Dursun, Tolga Fikret Tözüm.
Journal: Dentomaxillofac Radiol
Date: March 2020
An Alternative Treatment for Hopeless Implants: Coronal Resection
H Burak Kutlu, Samir Goyushov, Tolga F. Tözüm.
Journal: J Oral Biol Craniofac Res
Date: Apr-Jun 2020
Elevated Interleukin-17A Expression in Amlodipine-Induced Gingival Overgrowth
Siddika Selva Sume, Ezel Berker, Yagmur Ilarslan, Ozlem Ozer Yucel, Cagman Tan, Samir Goyushov, Sibel E Gultekin, Ilhan Tezcan.
Journal: J Periodontal Res
Date: October 2020
Three-Dimensional Calculation of Sinus Augmentation Volume after Maxillary Sinus Floor Elevation
Samir Goyushov, Erhan Dursun, Kaan Orhan, Tolga Tözüm.
Journal: Dent J
Date: May 2021
Dr. Samir Göyüşov
Accessory Mental/Buccal Foramina: Case Report and Review of Literature
Goyushov S, Tözüm MD, Tözüm TF.
Journal: Implant Dentistry
Date: October 2017
Transplantation of Autogenous Bone Block with an Osseointegrated Implant: Seedling Technique
[Additional details can be included here if available]
The 2nd Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference 2019: Summary and Consensus Statements: Group 1-Biological Aspects of Tooth Extraction, Socket Healing and Indications for Socket Preservation
Gintaras Juodzbalys, Povilas Daugela, Onurcem Duruel, Maria Helena Fernandes, Pedro de Sousa Gomes, Samir Goyushov, Lorena Mariano, Lukas Poskevicius, Arturas Stumbras, Tolga Fikret Tözüm.
Journal: J Oral Maxillofac Res
Date: September 5, 2019
Morphological Classification of Extraction Sockets and Clinical Decision Tree for Socket Preservation/Augmentation after Tooth Extraction: a Systematic Review
Gintaras Juodzhalys, Arturas Stumbras, Samir Goyushov, Onurcem Duruel, Tolga Fikret Tanim.
Journal: J Oral Maxillofac Res
Date: September 5, 2019
Mandibular Cortical Indices and Their Relation to Gender and Age in Cone-Beam Computed Tomography
Samir Goyushov, Erhan Dursun, Tolga Fikret Tözüm.
Journal: Dentomaxillofac Radiol
Date: March 2020
An Alternative Treatment for Hopeless Implants: Coronal Resection
H Burak Kutlu, Samir Goyushov, Tolga F. Tözüm.
Journal: J Oral Biol Craniofac Res
Date: Apr-Jun 2020
Elevated Interleukin-17A Expression in Amlodipine-Induced Gingival Overgrowth
Siddika Selva Sume, Ezel Berker, Yagmur Ilarslan, Ozlem Ozer Yucel, Cagman Tan, Samir Goyushov, Sibel E Gultekin, Ilhan Tezcan.
Journal: J Periodontal Res
Date: October 2020
Three-Dimensional Calculation of Sinus Augmentation Volume after Maxillary Sinus Floor Elevation
Samir Goyushov, Erhan Dursun, Kaan Orhan, Tolga Tözüm.
Journal: Dent J
Date: May 2021
| Arztbesuch | preis auf anfrage |
| Stammzellen Therapie | $6000 |
| Chirurgie der tiefen Hirnstimulation (THS). | $38000 |
| Arztbesuch | preis auf anfrage |
| Stammzellen Therapie | $15000 |
| Stammzelltherapie bei Autismus | $15000 |